Table 6.
Macrovesicular steatosis | Incidence of EAD, % | Fisher's exact test, two-tailed P value | |
---|---|---|---|
Sevoflurane group | Control group | ||
None (0%) | 11,1 (1 of 9) | 11,1 (1 of 9) | 1,000 |
Mild (1–30%) | 18,8 (3 of 16) | 60,0 (9 of 15) | 0,029 |
Moderate (31–60%) | 20,0 (1 of 5) | 83,3 (5 of 6) | 0,080 |
EAD: early allograft dysfunction.